by goldfishadmin | Feb 1, 2010 | News
Orphagen Pharmaceuticals announced today that it has been awarded a two year federal grant to further characterize a novel class of small molecule drugs with potential to treat circadian rhythm sleep disorders and more serious psychiatric illnesses, such as anxiety,...
by goldfishadmin | Jan 7, 2009 | News
Orphagen Pharmaceuticals, Inc., a privately held company (“Orphagen”) today announced that it has entered into a Collaboration and License Agreement with Japan Tobacco Inc., (“JT”) to discover, develop and commercialize drugs in the areas of immunology and...